ReviewInflammation2026
The Dual Role of Exosomes in Gout: From Inflammatory Amplifiers to Therapeutic Regulators.
Review in Inflammation, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Gout is a metabolic disorder where excessive MSU crystals are found in joints and adjacent tissues. When the crystals are deposited acutely, they typically trigger loud and uncontrollable local inflammation. As we know, the main goals of diagnosis and treatment of the disease are the reduction of serum uric acid levels and treatment of acute inflammation. Although these methods are useful, we are still facing many challenges: early risk detection, personalized treatment plan and management of comorbidities associated with gout. As nanoscale vesicles for intercellular communication, exosomes are also receiving much attention due to their possible roles in the regulation of inflammation, pathogenesis and progression. We review the functions of exosomes in gout. Various mechanisms are known that exosomes regulate gouty inflammation. When immune cells activate MSU crystals, they release exosomes carrying mature IL-1β, NLRP3 inflammatory components and pro-inflammatory miRNAs that induce local inflammation. Exosomes from mesenchymal cells or other cell types may have other functions, such as NLRP3 inhibition and M2-polarized macrophage transporting the inflammation and tissue repair. It was carried out on vesicles collected from blood, synovial fluid, urine of patients for clinical studies. These vesicles differ in size, protein and miRNA expression because of the different stages of gout and could be the disease indicator. Most studies are still preliminary, small sample size and non-standard detection and evaluation. To translate these results into practice, more extensive prospective clinical trials are needed. Native and engineered exosomes are promising anti-inflammatory agents, modulating the immune system and facilitating precise tissue repair. Exosomes likely link MSU crystal deposition, acute inflammation and systemic immune metabolic dysregulation. Identifying the specific cell locations involved in gout is important for developing diagnostic and therapeutic approach for gout at earlier stages.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.